EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest

Despite the fact that temozolomide (TMZ) has been widely accepted as the key chemotherapeutic agent to prolong the survival of patients with glioblastoma, failure and recurrence cases can still be observed in clinics. Glioma stem-like cells (GSCs) are thought to be responsible for the drug resistance. In this study, we investigate whether endothelial monocyte-activating polypeptide-II (EMAP-II), a pro-inflammatory cytokine, can enhance TMZ cytotoxicity on U87MG and GSCs or not. As described in prior research, GSCs have been isolated from U87MG and maintained in the serum-free DMEM/F12 medium containing EGF, b-FGF, and B27. TMZ and/or EMAP-II administration were performed for 72 h, respectively. The results showed that TMZ combined with EMAP-II inhibit the proliferation of U87MG and GSCs by a larger measure than TMZ single treatment by decreasing the IC₅₀. EMAP-II also enhanced TMZ-induced autophagy-mediated cell death and G2/M arrest. Moreover, we found that EMAP-II functioned a targeted suppression on mTOR, which may involve in the anti-neoplasm mechanism. The results suggest that EMAP-II could be considered as a combined chemotherapeutic agent against glioblastoma by sensitizing U87MG and GSCs to TMZ.     

Structural Insight of a Trimodular Halophilic Cellulase with a Family 46 Carbohydrate-Binding Module

Cellulases are the key enzymes used in the biofuel industry. A typical cellulase contains a catalytic domain connected to a carbohydrate-binding module (CBM) through a flexible linker. Here we report the structure of an atypical trimodular cellulase which harbors a catalytic domain, a CBM46 domain and a rigid CBM_X domain between them. The catalytic domain shows the features of GH5 family, while the CBM46 domain has a sandwich-like structure. The catalytic domain and the CBM46 domain form an extended substrate binding cleft, within which several tryptophan residues are well exposed. Mutagenesis assays indicate that these residues are essential for the enzymatic activities. Gel affinity electrophoresis shows that these tryptophan residues are involved in the polysaccharide substrate binding. Also, electrostatic potential analysis indicates that almost the entire solvent accessible surface of CelB is negatively charged, which is consistent with the halophilic nature of this enzyme.     

Yeast Cells Expressing the Human Mitochondrial DNA Polymerase Reveal Correlations between Polymerase Fidelity and Human Disease Progression

Mutations in the human mitochondrial polymerase (polymerase-γ (Pol-γ)) are associated with various mitochondrial disorders, including mitochondrial DNA (mtDNA) depletion syndrome, Alpers syndrome, and progressive external opthamalplegia. To correlate biochemically quantifiable defects resulting from point mutations in Pol-γ with their physiological consequences, we created “humanized” yeast, replacing the yeast mtDNA polymerase (MIP1) with human Pol-γ. Despite differences in the replication and repair mechanism, we show that the human polymerase efficiently complements the yeast mip1 knockouts, suggesting common fundamental mechanisms of replication and conserved interactions between the human polymerase and other components of the replisome. We also examined the effects of four disease-related point mutations (S305R, H932Y, Y951N, and Y955C) and an exonuclease-deficient mutant (D198A/E200A). In haploid cells, each mutant results in rapid mtDNA depletion, increased mutation frequency, and mitochondrial dysfunction. Mutation frequencies measured in vivo equal those measured with purified enzyme in vitro. In heterozygous diploid cells, wild-type Pol-γ suppresses mutation-associated growth defects, but continuous growth eventually leads to aerobic respiration defects, reduced mtDNA content, and depolarized mitochondrial membranes. The severity of the Pol-γ mutant phenotype in heterozygous diploid humanized yeast correlates with the approximate age of disease onset and the severity of symptoms observed in humans.     

Head group specificity in the requirement of phosphatidylcholine biosynthesis for very low density lipoprotein secretion from cultured hepatocytes

We have demonstrated that hepatic very low density lipoprotein (VLDL) secretion requires active phosphatidylcholine (PC) synthesis via either the CDP-choline pathway or phosphatidylethanolamine (PE) methylation pathway (Yao, Z., and Vance, D.E. (1988) J. Biol. Chem. 263, 2998-3004). In the present work, the head group specificity of phospholipid synthesis required for lipoprotein secretion was investigated in cultured hepatocytes isolated from choline-deficient rats. When N-monomethylethanolamine (0.1 mM) or N,N-dimethylethanolamine (0.1 mM) was added to the culture medium, the cells synthesized correspondingly phosphatidylmonomethylethanolamine (PMME) or phosphatidyldimethylethanolamine (PDME). However, the synthesis of PDME could correct the impaired VLDL secretion only to a limited extent, whereas the synthesis of PMME inhibited VLDL secretion. Although dimethylethanolamine did not promote VLDL secretion as well as choline, dimethylethanolamine altered the increased triacylglycerol synthesis in the choline-deficient cells as effectively as choline. Supplementation of the culture medium with ethanolamine (0.1 mM) had little effect on cellular PE or PC levels, nor was normal VLDL secretion resumed. However, the amounts of cellular PC and PE were both decreased when the medium was supplemented with N-monomethylethanolamine or N,N-dimethylethanolamine. These results suggest that the choline head group moiety of PC is specifically required for normal VLDL secretion and cannot be replaced with ethanolamine, monomethylethanolamine, or dimethylethanolamine. In addition, the impaired VLDL secretion from the choline-deficient hepatocytes could also be corrected by supplementation of betaine (0.2 mM) and homocysteine (0.2 mM), indicating the utilization of a methyl group from betaine for PC formation via methylation of PE.     

模拟增温对青藏高原多年冻土区小嵩草和藏嵩草生长与抗氧化特征的影响

采用开顶式增温小室(OTCs)方法模拟气候变暖,分别选取青藏高原腹地风火山地区高寒小嵩草草甸和高寒藏嵩草沼泽草甸优势物种小嵩草和藏嵩草为研究对象,对比分析增温处理下两种优势物种叶片的形态与生理特征变化,从而探索高寒植物对气候变暖的内在响应机理.结果表明: 增温显著增加了小嵩草叶片长度(40.0%)和叶片数量(72.7%),也显著增加了藏嵩草株高(11.9%)和叶片长度(19.3%),促进了两种优势植物的形态生长和地上生物量增加.增温处理下小嵩草和藏嵩草叶片的膜透性(电导率),活性氧(过氧化氢和超氧阴离子自由基),超氧化物歧化酶、过氧化物酶、抗坏血酸过氧化物酶和过氧化氢酶活性,丙二醛含量均没有显著变化.但抗坏血酸和游离脯氨酸含量在藏嵩草叶片内分别显著增加了29.8%和53.8%,而在小嵩草叶片内没有明显变化.可见,增温下小嵩草和藏嵩草均能够维持正常的抗氧化水平,以维持该区域优势植物生长;但藏嵩草生理过程对增温更加敏感.     

利用锌特异性探针HL~1示踪植物细胞外Zn~(2+)的分布

以拟南芥(Arabidopsis thaliana)和谷子(Setaria italic)为研究材料,利用锌特异性探针HL1,使用荧光分光光度仪、等温滴定热量测定仪(ITC200)和倒置荧光显微镜等仪器探究了该化学探针的特性以及植物细胞外游离Zn~(2+)的分布。结果表明,当HL1与不同元素溶液混合时,只与Zn~(2+)特异性结合,在紫外光(UV)激发下,发射出波长为500 nm的蓝色荧光;生成物的平衡解离常数KD=7.02×10–4 mol·L–1,具有很好的稳定性。拟南芥叶片中的Zn~(2+)分布于细胞间隙及叶表皮毛的外周和表层,且叶表皮毛的荧光强度具有明显的浓度依赖性;谷子叶片中的Zn~(2+)分布在细胞间隙以及维管组织。拟南芥根中的Zn~(2+)分布于根的伸长区,且荧光强度也明显地表现出与浓度相关。由此推断,根伸长区与Zn~(2+)运输有关,叶的维管组织是植物细胞外运输Zn~(2+)的主要途径,细胞间隙和叶表皮毛是植物储存Zn~(2+)的主要区域。HL1适用于检测细胞外Zn~(2+)的分布。     

珍稀濒危物种堇叶紫金牛高效快繁体系的建立

筛选堇叶紫金牛(Ardisia violacea)野生优株,以其当年新发带休眠腋芽茎段为外植体,通过启动培养、丛生芽诱导增殖、壮苗培养、生根培养和炼苗移栽等过程建立其组培快繁技术体系。研究结果表明,最佳启动培养基为MS+0.80 mg·L~(–1)KT+0.10 mg·L~(–1) NAA+0.10 mg·L~(–1) IBA,腋芽萌发率达92.60%;最佳丛生芽诱导增殖培养基为MS1+0.50 mg·L~(–1) TDZ+0.10mg·L~(–1) NAA,平均增殖系数达8.60;最佳壮苗培养基为MS+1.00 mg·L~(–1) KT+0.50 mg·L~(–1) NAA;最佳生根培养基为1/2MS+2.00 mg·L~(–1) IBA+1.00 mg·L~(–1) NAA+1.00 mg·L~(–1) AC,平均生根率达98.70%;采用松鳞和泥炭(2:1,v/v)作为炼苗基质,炼苗成活率可达85.30%。实验成功建立了堇叶紫金牛高效组培快繁技术体系,经验证该体系能够满足规模化生产的需求。